Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG and Rituximab for de novo DSA in Kidney Transplant
NCT04033276Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2019
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
A Phase 4 trial of intravenous immunoglobulin G in antibody mediated rejection (AMR), sponsored by Seoul National University Hospital. Started Jan 2019; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
antibody mediated rejection (AMR)
Beyond the preview
Go deeper on NCT04033276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04033276.